Live Breaking News & Updates on Vaccine export

Stay informed with the latest breaking news from Vaccine export on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Vaccine export and stay connected to the pulse of your community

With Booster Doses, Shots for Children, Will Govt Take a More Pragmatic View on Vaccine Procurement?

We once again face the prospect of there being only one vaccine for our adult booster-dose campaign and one vaccine to vaccinate minors.

Karnataka , India , United-kingdom , Israel , Texas , United-states , Malur , Pune , Maharashtra , Houston , Ankleshwar , Gujarat

India Resuming Vaccine Exports Certainly Helps: IMF's Gita Gopinath On Reducing Vaccine Deficit

Gita Gopinath, chief economist at the International Monetary Fund, has said that 75 countries won't be able to achieve 40 per cent COVID vaccination coverage by the end of 2021, based on current projections. "What's very very important is what India does on the export front," she said, adding, "low-income countries, the ones that are getting the vaccines from COVAX, depended a lot on exports from India. Resuming those exports certainly helps."

India , India-resuming-vaccine-exports-certainly-helps , Gita-gopinath , Gita-gopinath-to-ndtv , Gita-gopinath-on-india-vaccination , Imf-chief , Covid-19-vaccination , Coronavirus-vaccination , Vaccine-export , Reality-check ,

Not right time to talk about vaccine supply abroad says India latest news

As the demand for COVID-19 vaccines rises globally, India on Thursday said it would not be right to talk about the supply of jabs to other countries at the moment as it is currently ramping up domestic production for its own inoculation programme.

India , Afghanistan , United-states , Guwahati , Assam , Arindam-bagchi , Pfizer , Us-administration , Affairsv-muraleedharan , Johnson , Ministry-of-external-affairs , Image-source

COVID-19: Not Right Time To Talk About Vaccine Supply Abroad: Centre

As the demand for COVID-19 vaccines rises globally, India on Thursday said it would not be right to talk about the supply of jabs to other countries at the moment as it is currently ramping up domestic production for its own inoculation programme.

India , United-states , Arindam-bagchi , Pfizer , Us-administration , Affairsv-muraleedharan , Johnson , Ministry-of-external-affairs , External-affairs , Lok-sabha , External-affairsv-muraleedharan , External-affairs-ministers-jaishankar

Why India can't stop exports of the vax for long


Why India can’t stop exports of the vax for long
Premium
The Centre has got a lot of flak for having exported vaccines starting January. India has now stopped exports, but Serum Institute of India (SII) has said it hopes to resume them by the year-end. Mint explains why India cannot halt vaccine exports indefinitely.
Share Via
Read Full Story
The Centre has got a lot of flak for having exported vaccines starting January. India has now stopped exports, but Serum Institute of India (SII) has said it hopes to resume  them by the year-end. Mint explains why India cannot halt vaccine exports indefinitely.

India , Serum-institute-of-india , Serum-institute , Covid-19 , Covid-19-vaccine , Vaccine-export , Vaccine-exports , Supply-chain , Covid-19-vaccines-manufacturing , Vaccine-ingredients , Sii

Delay in vaccine export by India to deal blow to poorer countries: Report


 
Covid-19 vaccination programmes across Africa and much of the developing world will suffer big delays after India, the worlds biggest vaccine producer, said that it would not be exporting the Oxford/AstraZeneca vaccine until the end of the year, The Guardian reported.
The decision is likely to leave the Covax global vaccine-sharing facility, which helps the poor countries, facing a shortfall of hundreds of millions of doses, the report said.
"We continue to scale up manufacturing and prioritise India. We also hope to start delivering to Covax and other countries by the end of this year," Adar Poonawalla, the chief executive of Serum Institute of India (SII), said on Tuesday.

India , Nepal , Bangladesh , Oxford-astrazeneca , Jhalak-gautam , Adar-poonawalla , Tedros-adhanom-ghebreyesus , Joe-biden , Astrazeneca , World-health-organization , Serum-institute-of-india , Johnson

Bharat Biotech has declined to supply any more vaccines to Delhi, says Manish Sisodia


Bharat Biotech has declined to supply any more vaccines to Delhi, says Manish Sisodia
Sisodia says Delhi demanded 1.34 crore doses of Covid-19 vaccines, 67 lakhs each of Covaxin and Covishield, but Bharat Biotech wrote it can't provide as dispatches are being made as per the directives of concerned government officials
BusinessToday.In | May 12, 2021 | Updated 13:21 IST
Delhi Deputy CM Manish Sisodia
In yet another SOS to the Centre, Delhi Deputy CM Manish Sisodia said today that Bharat Biotech has declined to supply any more vaccines to the national capital. He said Delhi's reserve stock of Covid-19 vaccine is exhausted, and that the Centre should carry out its responsibility and stop all exports to fulfil the domestic demand.

Delhi , India , Cambridge , Cambridgeshire , United-kingdom , Bharat , Satyendar-jain , Manish-sisodia , Delhi-health , Serum-institute-of-india , Vaccination-centre , Delhi-deputy

Over 84 per cent vaccine doses sent abroad due to commercial, licensing liabilities: BJP

Sending over 5.50 crore vaccine doses abroad were the compulsion of the two Indian manufacturers as it was part of their commercial and licensing liabilities, Patra said.

Delhi , India , Bharat , Narendra-modi , Rahul-gandhi , Sambit-patra , Arvind-kejriwal , Astrazeneca , Aam-aadmi-party , Serum-institute-of-india , Bharatiya-janata-party , Serum-institute